Chemical degradation of wastes of antineoplastic agents amsacrine, azathioprine, asparaginase and thiotepa

Annals of Occupational Hygiene

Volumn 42, Issue 4, 1998, Pages 259-266

  Barek, J ^a   Cvacka J ^a   Zima, J ^a   De Meo M ^b   Laget, M ^b   Michelon, J ^c   Castegnaro, M ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS; BIODEGRADATION; CHEMICAL WASTES; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN PEROXIDE; IRON COMPOUNDS; MUTAGENESIS; OXIDATION; SODIUM COMPOUNDS;

REAGENTS; SODIUM HYPOCHLORITE;

OCCUPATIONAL RISKS;

AMSACRINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; AZATHIOPRINE; FERROUS CHLORIDE; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; THIOTEPA;

AMES TEST; ARTICLE; CHEMICAL WASTE; CONTROLLED STUDY; DEGRADATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL WASTE; METABOLIC ACTIVATION; MUTAGENICITY; OXIDATION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; TIME; WASTE DISPOSAL;

AMSACRINE; ANTINEOPLASTIC AGENTS; ASPARAGINASE; AZATHIOPRINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HAZARDOUS WASTE; THIOTEPA;

EID: 0032077417     PISSN: 00034878     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4878(98)00023-4     Document Type: Article

References (27)

1. Allwood, M. and Wright P. (1993) The cytotoxics handbook, 2nd edn. Radcliffe Medical Press, Oxford
2. Barek, J., Castegnaro, M., Malaveille, C., Brouet, I. and Zima, J. (1987) A method for the efficient degradation of melphalan into non-mutagenic products. Microchem. J. 36, 192-197.
3. Benvenuto, J. A., Conor, T H., Monteith, D. K., Laidlaw, J. L., Adams, S C., Matney, T. S. and Theiss, C. (1993) Degradation and inactivation of antitumor drugs. J. Pharm. Sci. 82, 988-991.
4. Cass, Y. and Musgrave, C. F. (1992) Guidelines for safe handling of excreta contaminated by cytotoxic agents. Am. J. Hosp. Pharm. 49, 1957-1958.
5. Castegnaro, M., Adams, J., Armour, M. A , Barek, J., Benvenuto, J., Confalonieri, C., Goff, V. and and Ludeman, S. (1985) Laboratory decontamination and destruction of carcinogens in laboratory wastes: some antineoplastic agents. (IARC scientific publications no. 73) IARC, Lyon
6. Castegnaro, M., Barek, J , Frémy, J. M., Miragha, M., Sansone, E. B.and Telling, G.M. (eds)(1991) Laboratory decontamination and destruction of carcinogens in laboratory wastes: some mycotoxins. (IARC scientific publications no. 113) IARC, Lyon.
7. Castegnaro, M., De Méo, M., Laget, M., Michelon, J., Garren, L., Sportouch, M.H. and Hansel, S. (1997) Chemical degradation of wastes of antineoplastic agents Part 2: six anthracyclines: idarubicin, doxorubicin, epirubicin, pirarubicin, aclarubicin and daunorubicin (Submitted for publication).
8. Čoupek, J. and Vinš, I. (1994) Hydroxethyl methacrylate-based sorbents for high-performance liquid chromatography of proteins. J. Chromatography A 658, 391-398.
9. De Méo, M., Laget, M . Di Giorgio, C., Guiraud, H., Botta, A., Castegnaro, M. and Dumenil, G. (1996) Optimization of the Salmonella mammalian microsome assay for urine mutagenesis by experimental designs. Mutat Res. 340, 51-65
10. De Méo, M , Mérono, S., De Baille, A. D., Botta, A., Laget, M., Guiraud, H. and Dumenil, G. (1995) Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials. Int. Arch. Occup. Environ. Health 66, 363-368.
11. Fell, A. E., Plag, M. and Neil, J. M (1979) Stability-indicating assay for azathioprine and 6-mercaptopurine by reversed-phase high-performance liquid chromatography. J. Chromatography 186, 691-704.
12. Guinee, E. P., Beumaan, G. H , Hageman, G., Welle, H. and Kemjan, J. C. S (1991) Guidelines for the safe handling of excreta contaminated by cytostatic agents. Pharm. Weekbl. (Sci. Ed.) 13, 78-82.
13. Hansel, S., Castegnaro, M., Sporotuch, M. H., De Méo, M., Milhavet, J. C., Laget, M. and Dumenil, G. (1997) Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan. Int Arch. Occup. Environ.Health 69, 109-114.
14. International Agency for Research on Cancer (1979) Report on the first meeting of the working group on methods for containment, destruction and disposal of carcinogenic waste from laboratories.(IARC technical report no 79 002). IARC. Lyon.
15. International Agency for Research on Cancer (1994) IARC monograph on the evaluation of carcinogenic risk to humans: list of IARC evaluations. IARC, Lyon.
16. Jurhna, J. F. and Paxton, J. W. (1983) High-performance liquid chromatography for the determination of 4′-(9-acridinylamino)methanesulfon-m-anisidine in plasma 276, pp 367-374.
17. Kalghatgi, K. and Horvath, C. (1987) Rapid analysis of proteins and peptides by reversed-phase chromatography. J Chromatography 398, 335-339.
18. Lowry, O. H , Rosebrough, A. L., Farr, A L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent J. Biol. Chem. 193, 265-275.
19. Lunn, G., Sansone, E. B , Andrew, A. W. and Hellwig, L. C. (1989) Degradation and disposal of some antineoplastic drugs. J Pharm. Sci. 78, 652-659.
20. Maa, Y. F. and Horvath, C (1988) Rapid analysis of proteins and peptides by reversed-phase chromatography with polymeric micropellicular sorbents. J. Chromatography 445, 71-86.
21. Maron, D M. and Ames, B. N. (1983) Revised methods for the Salmonella mutagenicity test. Mut. Res. 113, 173-215.
22. Monteith, D. K., Conor, T. H and Benvenuto. J. A. (1987) Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy. Environ Mol. Mutagen 10, 341-356.
23. cne édition. Maisonneuve, Moulin-les-Metz.
24. Rousselin, X. and Stücker, I. (1990) Les medicaments cytostatiques en milieu de soins. 1. Toxicite et risques professionnels (Fiche medico-technique no. 33). Document pour Medecins du Travail 43, 215-225.
25. Sessink, P J. M., Boer, K. A., Scheefhals, A. P. H., Anzion, R. B , Bos, R P. (1992) Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int. Arch Occup. Environ. Health 64, 105-112.
26. Sorsa, M., Hemminki, K. and Vainio, H. (1985) Occupational exposure to anticancer drugs potential and real hazard Mutat Res. 154, 135-149.
27. Tinsley, P. W., O'Dwyer, P. J., LaCreta, F. P. (1889) High performance liquid Chromatographic analysis of N,N′,N′-triethylenethiophosphoramide in human plasma. J. Chromatography 495, 318-323